Items tagged with Treatment
Zimbabwe faces troubling spike in cases of multidrug-resistant TB (post with simple image)
- About eight years ago, 44-year-old Tilda Chihota was struck with tuberculosis which kept her bed-ridden for over six months at her rural home in Zimbabwe’s Mwenezi district, 144 kilometres southwest of Masvingo, the country’s oldest town.
Phase 2a published results show the potential of a new TB regimen with novel drugs bedaquiline and pretomanid (PA-824) (post with simple image)
Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial
TB Alliance advances next-generation TB drug candidate into clinical testing (post with simple image)
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years.
Stop TB Partnership's Global Drug Facility (GDF) achieves historic price reduction for MDR-TB drug Cycloserine (post with simple image)
This price reduction is expected to save up to USD 22 million annually, enabling treatment for more people living with MDR-TB.
Call to action: Accelerate access to DR-TB drugs (post with simple image)
SIGN ON LETTER to global actors and drug companies: Please provide organizational sign-ons by 6 March.
Call to action: Accelerate access to DR-TB drugs (post with simple image)
А letter from 89 organizations urges action to accelerate access to new and repurposed drugs to treat drug-resistant tuberculosis.
Global Phase 3 “STAND” trial launched to test new tuberculosis drug regimen PaMZ to shorten, improve treatment (post with simple image)
STAND trial will take place in approximately 50 study sites in Africa, Asia, Caribbean, Eastern Europe, and Latin America; Results published in The Lancet show PaMZ’s promise to dramatically shorten and simplify therapy for patients with drug-resistant TB; Regimen could improve treatment for those with drug-sensitive TB and those with HIV co-infection.
The Lancet: Results of Phase 2b trial of novel TB regimen PaMZ show potential to shorten, improve TB treatment (post with simple image)
Phase 3 STAND trial launched to advance PaMZ through final stage of testing.
Leading medical organizations team up to bring new TB treatments to those in need (post with simple image)
International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
MSF issue brief: Ready, set, slow down (post with simple image)
New and promising DR-TB drugs are grabbing headlines but not reaching patients.
Page 90 of 108 · Total posts: 0
←First 89 90 91 Last→